Skip to main content
. 2020 Nov 6;38(51):8090–8098. doi: 10.1016/j.vaccine.2020.11.013

Table 2.

Estimation results of willingness to pay models for a COVID-19 vaccine in Ecuador.

Variable Model 1 Model 2 Model 3
Constant 4.342*** 4.260*** 3.479***
(0.112) (0.392) (0.545)
Duration of protection 0.259** 0.014** 0.259**
(0.127) (0.007) (0.128)
Efficiency of protection 0.028 0.001 0.053
(0.127) (0.005) (0.127)
Contracting probability −0.001
(0.003)
Hospitalized probability 0.006**
(0.003)
Death probability 0.005
(0.004)
Age 0.003
(0.006)
Household size −0.003
(0.033)
Income (thousands of dollars) 0.337***
(0.101)
Gender (Female = 1, Male = 0) −0.039
(0.134)
College education (Yes = 1, No = 0) 0.120
(0.156)
Health insurance (Yes = 1, No = 0) 0.226
(0.140)
Employment status (Employed = 1, Other = 0) 0.274*
(0.164)
Knowledge score 0.0002
(0.038)
Region of residence
Pichincha −0.300
(0.183)
Guayas −0.357*
(0.213)
Sierra and Amazon −0.170
(0.202)



Sigma (σ) 1.686*** 1.686*** 1.621***
Sample size 972 972 921
Wald Chi2 4.21 4.21 44.68
P-value (Prob > Chi2) 0.12 0.12 0.0002
Log likelihood −1156.06 −1156.06 −1059.061

Notes. The parametric model used is a log-normal distribution with parameters μandσ,μ=Xi'β.

Standard errors in parenthesis.

***indicates significance at 1%, ** indicates significance at 5%, and * indicates significance at 10%.